This MedLibrary.org supplementary page on Purdue Pharma is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Purdue Pharma L.P., is a privately-held pharmaceutical company founded by physicians. It is located in Stamford, Connecticut.
Purdue is best known for painkillers, but they have also branched into other areas such as oncology and nutraceuticals.
In its early years, Purdue was known for its antiseptic product, Betadine Solution, and its Senokot laxatives. Today, it is best known for its pain-treatment products, MS Contin Tablets and OxyContin Tablets.
In July 2007, Purdue Frederick Company, a shell company of Purdue Pharma, was criminally convicted in US Federal Court in Virginia with misleading patients and physicians as to the addictive and abusive capabilities of OxyContin. They and their three CEO's Michael Friedman, Howard Udell and Paul Goldenheim pled guilty and were sentenced. The 3 convicted felons were sentenced to 400 hours of community service at a drug rehab facility and were put on probation. Their actions have resulted in scores of deaths and addictions in every state in the country. Marianne Skolek, Activist for Victims of OxyContin and Purdue Pharma continues in her efforts to further expose them for their criminal activities. Skolek recently filed a complaint with the FDA and Attorney Generals throughout the country against Purdue Pharma for their marketing to pregnant women for pain in pregnancy. In addition, Skolek has charged them with a violation of their probation for this marketing ploy which will result in scores of addictions and deaths of mothers and newborns.
Contents |
History
Purdue was founded by Dr. John Purdue Gray and George Frederick Bingham in 1892 in New York City. It came under new private ownership in 1952. It currently employs about 1,200 people.[1]
Structure
The company's different branches include Purdue Pharma L.P., The Purdue Frederick Company, Purdue Pharmaceutical Products L.P., and Purdue Products L.P. (www.pharma.com).
The company's manufacturing takes place at three different sites, which include: Purdue Pharmaceuticals L.P., a plant located in Wilson, North Carolina; The P.F. Laboratories Inc. in Totowa, New Jersey; and Rhodes Technologies L.P. in Coventry, Rhode Island. Purdue Pharma L.P. also has research labs located in Cranbury, New Jersey. OxyContin is currently legally and illegally distributed throughout the U.S., Canada, and Mexico. Legal distribution takes place from the P.F. Laboratories Inc. in Totowa, New Jersey.
Prescription drug abuse
Purdue has been involved in measures against prescription drug abuse, particularly of its well known Oxycontin brand. In 2001, Connecticut Attorney General Richard Blumenthal issued a statement urging Purdue to take action regarding abuse of Oxycontin. Blumenthal noted that while Purdue seemed sincere, there was little action being taken beyond "cosmetic and symbolic steps."[2] After Purdue announced plans to reformulate the drug, Blumenthal noted that this would take time, and that "Purdue Pharma has a moral, if not legal, obligation to take effective steps now that address addiction and abuse even as it works to reformulate the drug."[3] The company has since implemented a comprehensive program designed to assist in detection of the illegal trafficking and abuse of prescription drugs without compromising patient access to proper pain control.
In May 2007, the company pleaded guilty to misleading the public about Oxycontin's risk of addiction. Purdue Pharma, its president, top lawyer, and former chief medical officer agreed to pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications.[4]
The State of Kentucky vs. Purdue
On October 4, 2007 Kentucky officials sued Purdue because of widespread Oxycontin abuse in Appalachia. A lawsuit filed by Kentucky Attorney General Greg Stumbo and Pike County officials demands millions in compensation from drug maker Purdue Pharma. [5]
Cerumenex and Hearing Loss
In January 2008, the Canadian Broadcasting Corporation reported [1] on a study which linked the use of a Pharma Purdue product "Cerumenex" (an eardrop treatment for softening wax buildup) to hearing loss in chinchillas. The study's author believes the results are applicable to humans because they have a similar hearing mechanism.
References
- ^ FAQs from Purdue Pharma official website
- ^ Connecticut Attorney General's Office Press Release: Attorney General Calls For Major Changes In Marketing And Distribution Of Oxycontin
- ^ Connecticut Attorney General's Office Press Release: Attorney General's Statement On Purdue Pharma's Announcement That It Intends To Reformulate Oxycontin
- ^ OxyContin Maker, Execs Guilty of Deceit
- ^ Kentucky sues makers of OxyContin
External links
Wikipedia content modification information:
- This page was last modified on 10 September 2008, at 20:35.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Purdue Pharma".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.